Lisa Lavin is the founder and CEO of Ōmcare, a subsidiary of Anser Innovation. Ōmcare is a digital health company pioneering products that enable remote care. Ōmcare extends the reach of caregivers and redefines medication adherence.

Lisa has over 25 years of experience building new businesses from the ground up within the healthcare and high-tech sectors. Lisa is active in local and national organizations that support entrepreneurialism and women in business. Lisa is a Minnesota Cup Division winner, Eureka Award winner for Innovation, was recognized by Minneapolis / St. Paul Business Journal as one of 25 Woman to Watch, Minnesota Business’ Real Power 50, and The New York Observer’s 2020 List of the Hottest “Flyover Tech” Companies in Digital Health.

Give us the Ōmcare elevator pitch.

Ōmcare is a digital health company pioneering products that enable remote care in the home. Ōmcare extends the reach of caregivers and enables visual confirmation of real medication adherence, resulting in lower healthcare costs and healthier populations. Ōmcare is changing the way the world cares.

What have been the company’s most exciting milestones thus far?

  • Ōmcare has formalized an agreement with Ecumen and Thrifty White Pharmacy for the pilot of the Ōmcare Home Health Hub. Ōmcare is expanding partnerships with other pharmacies, providers, payers, and channel partners for national launch later this year.
  • Ōmcare’s third patent was published July 9, 2019. Other patents are pending.
    • US 9,202,011, US 10,078,732 and US 10,347,377
  • Ōmcare has attracted top talent with over 150 years of combined experience in healthcare and innovation. The company and its leadership have been recognized as Minnesota Cup Division winner, Eureka Award winner for Innovation, Minneapolis / St. Paul Business Journal 25 Woman to Watch, and Minnesota Business’ Real Power 50 and was named among the “20 Hottest Flyover Tech Companies” by The New York Observer, based on insights from a panel of healthcare and business experts at the 38th Annual JP Morgan Healthcare Conference.

Read the full interview from Medical Alley.